Point of Care Diagnostic Market Share | Trends, Applications, Analysis, Growth, And Forecast To 2030

Point-of-care (POC) diagnostics Market Overview:

Point-of-care (POC) diagnostics Market refers to diagnostic testing that is performed at or near the location where the patient is being treated. This type of testing allows for quick and convenient testing, and is typically performed using portable or handheld devices that can produce results in a matter of minutes.

The Point of Care Diagnostic Market was analyzed which was worth USD 35.4 Billion in the year 2021, expecting a CAGR of 7.03% during the forecast period (2022-2030), and the market is projected to be valued at USD 65.25 Billion by 2030.

POC testing is performed in a variety of settings, including hospitals, clinics, and in the home. The tests can be used to diagnose a range of conditions, including infectious diseases, chronic conditions, and pregnancy, among others. POC diagnostics is particularly useful in emergency and critical care settings, where rapid diagnosis and treatment are essential.

Get Sample Report Here: https://marketresearchcommunity.com/sample-request/?rid=2193

The growth of the point-of-care diagnostic market is driven by the increasing incidence of chronic diseases, growing demand for rapid and accurate diagnoses, and the increasing adoption of POC devices. The market is expected to continue to grow in the coming years, as the demand for POC testing continues to increase and technological advances in POC testing continue to be made.

The goal of POC testing is to speed up the diagnostic process, reduce the time to treatment, and improve patient outcomes. By providing rapid results, POC testing can help healthcare providers to make more informed decisions about treatment and management of patients.

Point-of-care (POC) diagnostics Market Includes Key Players:

• Johnson and Johnson
• Siemens AG
• Nova Biomedical
• Danaher Corporation
• bioMrieux SA
• Abbott Laboratories
• Hoffmann La Roche Ltd
• Sinocare Inc.
• Sysmex corporation
• Becton Dickinson and Company

The Point-of-care (POC) diagnostics market is segmented into various Product, Purchase, Platform, End User including Sub segments such as:

• By Product: Glucose Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Fecal Occult Testing Products, Cardiometabolic Monitoring Products, Pregnancy & Fertility Testing Products, Cholesterol Testing Products, Cancer Marker Testing Products, Urinalysis Testing Products, Haematology Testing Products, Drugs-of-abuse Testing Products, Other POC Products
• By Purchase: OTC Testing Products, Prescription-based Testing Products
• By Platform: Lateral Flow Assays, Immunoassays, Microfluidics, Molecular Diagnostics, Dipsticks
• By End User: Professional Diagnostic Centers, Research Laboratories, Home Care, Others
• By Geography: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Geographically, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest Point-of-care (POC) diagnostics Market Share, due to the high incidence of chronic diseases, increasing demand for rapid and accurate diagnoses, and a strong healthcare infrastructure. Asia-Pacific is expected to grow at the highest rate, due to the increasing adoption of POC devices, the growing number of diagnostic laboratories, and the increasing healthcare spending in the region.

Market Research Community

Email: [email protected]